Genetic basis for activity differences between vancomycin and glycolipid derivatives of vancomycin

  • U. S. Eggert
  • , N. Ruiz
  • , B. V. Falcone
  • , A. A. Branstrom
  • , R. C. Goldman
  • , T. J. Silhavy
  • , D. Kahne

Research output: Contribution to journalArticlepeer-review

Abstract

Small molecules that affect specific protein functions can be valuable tools for dissecting complex cellular processes. Peptidoglycan synthesis and degradation is a process in bacteria that involves multiple enzymes under strict temporal and spatial regulation. We used a set of small molecules that inhibit the transglycosylation step of peptidoglycan synthesis to discover genes that help to regulate this process. We identified a gene responsible for the susceptibility of Escherichia coli cells to killing by glycolipid derivatives of vancomycin, thus establishing a genetic basis for activity differences between these compounds and vancomycin.

Original languageEnglish (US)
Pages (from-to)361-364
Number of pages4
JournalScience
Volume294
Issue number5541
DOIs
StatePublished - Oct 12 2001

All Science Journal Classification (ASJC) codes

  • General

Fingerprint

Dive into the research topics of 'Genetic basis for activity differences between vancomycin and glycolipid derivatives of vancomycin'. Together they form a unique fingerprint.

Cite this